SHANGHAI, March 18 (Xinhua) -- A Chinese research team has developed a multicellular scaffold based on inorganic bioceramics for treating tendon-to-bone injuries.
Restriction of motor activity due to loss of natural structure is a major cause of decreased life quality in patients suffering from tendon-to-bone injuries.
To solve this problem, the research team, led by the Shanghai Institute of Ceramics (SIC) of the Chinese Academy of Sciences, combined manganese silicate (MS) nanoparticles with tendon/bone-related cells to construct an immunomodulatory multicellular scaffold to achieve integrated tendon-to-bone regeneration.
The scaffold not only demonstrated diverse biological activities in vitro, but also achieved immune regulation, multi-tissue integration regeneration and motor function recovery in a variety of animal models of rotator cuff injury.
The study provides a new concept for achieving immunomodulation and integrated regeneration of tendon-bone and other tissue interfaces, said Wu Chengtie with the SIC, who led the research.
The study was recently published in the journal Science Advances.
(Editor:Fu Bo)
Beyoncé wows her fans while offering a rare glimpse at her stunning natural hair
Canadian gov't announces plan to solve national housing crisis
German chancellor arrives in SW China
White House approved more bombs to Israel on day of deadly Israeli attack on aid workers: WAPO
Tennis power couple Katie Boulter and Alex de Minaur look loved
Meet Donald Trump's glamorous right
Antique book archive inaugurated in Beijing
Chinese vice president meets Cambodian King, Queen Mother
Supreme Court to decide on Trump federal prosecution immunity
New book chronicles ecological civilization along Lijiang River
Tragedy as five migrants die crossing Channel trying to reach Britain
GENERAL JACOB NAGEL: Why Israel's failure to strike back at Iran could lead to NUCLEAR WAR